Touret Franck相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

In Vitro and In Vivo Models for Drug Development Against Two Hemorrhagic Hareavirales: Rift Valley Fever and Crimean Congo Hemorrhagic Fever Viruses

体外和体内模型用于开发针对两种出血性哈雷病毒（裂谷热病毒和克里米亚-刚果出血热病毒）的药物

期刊:Viruses-Basel

影响因子:3.5

doi:10.3390/v18030386

Chaput, Sarah; Nougairède, Antoine; Touret, Franck

发表日期：2026

文献求助收藏

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19

药理学如何帮助我们克服药物重定位为抗病毒药物以治疗新出现的病原体的挑战？以新冠肺炎为例

期刊:Cts-Clinical and Translational Science

影响因子:2.8

doi:10.1111/cts.70505

Ben Ghezala, Inès; Peiffer-Smadja, Nathan; Solas, Caroline; Nougairède, Antoine; Touret, Franck; Bardou, Marc

发表日期：2026

文献求助收藏

Virological characterization of SARS-CoV-2 BA.2.86 variants by assessing antiviral susceptibility, in vivo infectivity and replicative fitness

通过评估抗病毒药物敏感性、体内感染性和复制适应性，对SARS-CoV-2 BA.2.86变异株进行病毒学表征。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-27481-0

Giraud, Emilie; Piorkowski, Géraldine; Driouich, Jean-Sélim; Bernadin, Ornéllie; Durand, Cyrielle; Gilles, Magali; Amaral, Rayane; van der Werf, Sylvie; de Lamballerie, Xavier; Agou, Fabrice; Nougairède, Antoine; Touret, Franck

发表日期：2025

文献求助收藏

Structure-Based Rational Design of a Selective Hydrolase Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus-2 Nsp3 Macrodomain

基于结构的严重急性呼吸综合征冠状病毒2 Nsp3宏结构域选择性水解酶抑制剂的合理设计

期刊:Chembiochem

影响因子:2.8

doi:10.1002/cbic.202500593

Krishnathas, Robin; Mineev, Konstantin S; Fourkiotis, Nikolaos K; Touret, Franck; Sideras-Bisdekis, Christos; Tsika, Aikaterini C; Gande, Santosh Lakshmi; Linhard, Verena; Sreeramulu, Sridhar; Lennartz, Frank; Weiss, Manfred S; Coutard, Bruno; Spyroulias, Georgios A; Schwalbe, Harald

发表日期：2025

文献求助收藏

Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir

基因组监测揭示了一种登革热2型病毒流行谱系，该谱系对莫斯诺登革病毒的敏感性显著降低。

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-024-52819-z

Bouzidi, Hawa Sophia; Sen, Selin; Piorkowski, Géraldine; Pezzi, Laura; Ayhan, Nazli; Fontaine, Albin; Canivez, Thomas; Geulen, Manon; Amaral, Rayane; Grard, Gilda; Durand, Guillaume André; de Lamballerie, Xavier; Touret, Franck; Klitting, Raphaëlle

发表日期：2024

文献求助收藏

Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants

SARS-CoV-2康复患者体内中和和增强单克隆抗体：早期变异株感染的经验教训及其对塑造新出现变异株的影响

期刊:Emerging Microbes & Infections

影响因子:7.5

doi:10.1080/22221751.2024.2307510

Coutant, Frédéric; Touret, Franck; Pin, Jean-Jacques; Alonzo, Marina; Baronti, Cécile; Munier, Sandie; Attia, Mikaël; de Lamballerie, Xavier; Ferry, Tristan; Miossec, Pierre

单克隆抗体

发表日期：2024

文献求助收藏

From the "One-Molecule, One-Target, One-Disease" Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections

从“单分子、单靶点、单疾病”理念转向寻找治疗非脊髓灰质炎肠道病毒（NPEV）感染的多靶点疗法

期刊:Pharmaceuticals

影响因子:4.8

doi:10.3390/ph17091218

Roux, Hugo; Touret, Franck; Rathelot, Pascal; Vanelle, Patrice; Roche, Manon

发表日期：2024

文献求助收藏

Current status of pathogen handling in European laboratories: focus on viral inactivation process

欧洲实验室病原体处理的现状：重点关注病毒灭活过程

期刊:Frontiers in Bioengineering and Biotechnology

影响因子:4.8

doi:10.3389/fbioe.2024.1422553

Pastorino, Boris; Touret, Franck; Gilles, Magali; De Lamballerie, Xavier; Charrel, Remi N

发表日期：2024

文献求助收藏

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns

对莫努匹拉韦抗SARS-CoV-2的进一步临床前表征：抗病毒活性决定因素和病毒基因组改变模式

影响因子:3.6

doi:10.1016/j.heliyon.2024.e30862

Petit, Paul-Rémi; Touret, Franck; Driouich, Jean-Sélim; Cochin, Maxime; Luciani, Léa; Bernadin, Ornéllie; Laprie, Caroline; Piorkowski, Géraldine; Fraisse, Laurent; Sjö, Peter; Mowbray, Charles E; Escudié, Fanny; Scandale, Ivan; Chatelain, Eric; de Lamballerie, Xavier; Solas, Caroline; Nougairède, Antoine

发表日期：2024

文献求助收藏

Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model

在非人灵长类动物模型中，Sotrovimab 对 SARS-CoV-2 omicron 变异株 BQ.1.1 仍保持活性

影响因子:3.6

doi:10.1016/j.heliyon.2023.e16664

Hérate, Cécile; Marlin, Romain; Touret, Franck; Dereuddre-Bosquet, Nathalie; Donati, Flora; Relouzat, Francis; Junges, Laura; Galhaut, Mathilde; Dehan, Océane; Sconosciuti, Quentin; Nougairède, Antoine; de Lamballerie, Xavier; van der Werf, Sylvie; Le Grand, Roger

发表日期：2023

文献求助收藏